Cellectar (CLRB) Fundamental Analysis: Revenue, Earnings & Valuation

6.88 / 10

Outperform

Fundamental score is 6.88/10 (Outperform). Strong points include high interest coverage, PB‑ROE advantage, solid asset‑MV and revenue‑MV, robust inventory turnover and revenue growth. A weakness is a high current‑liabilities‑to‑total‑liabilities ratio, but overall outlook remains promising.

Analysis Checks(9/10)

Revenue-MV

Value-0.11

Score3/3

Weight31.02%

1M Return8.11%

Total operating revenue (YoY growth rate %)

Value134.00

Score2/3

Weight0.43%

1M Return0.13%

Inventory turnover ratio

Value103.94

Score2/3

Weight-3.54%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value93.88

Score1/3

Weight-4.95%

1M Return-1.69%

PB-ROE

Value8.01

Score3/3

Weight39.08%

1M Return9.18%

Long-term debt to working capital ratio (%)

Value0.03

Score2/3

Weight-1.10%

1M Return-0.35%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-3.60%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value177.16

Score2/3

Weight0.17%

1M Return0.05%

Cost of sales ratio (%)

Value64.41

Score2/3

Weight-3.40%

1M Return-1.13%

Asset-MV

Value-0.55

Score2/3

Weight45.88%

1M Return11.12%

Is CLRB undervalued or overvalued?

CLRB scores 6.88/10 on fundamentals and holds a Discounted valuation at present. Backed by its -170.27% ROE, 0.00% net margin, -0.49 P/E ratio, 1.07 P/B ratio, and 77.14% earnings growth, these metrics solidify its Outperform investment rating.